Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'The Global Market for Point of Care Diagnostics - Major Players and Key Issues' returned 74 results - Page 1 of 4   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Blood Gas And Electrolyte Analyzers - Global Strategic Business Report   Global Industry Analysts, Inc., Jan 2011, Pages: 332 Purchases Assets of Diametrics i-STAT Inks Distribution Agreement with Fuso 16. FOCUS ON SELECT GLOBAL PLAYERS Abaxis, Inc. (USA) Abbott Point-of-Care, Inc. (USA) Beckman Coulter, Inc. (USA Immunoassay Systems - Global Strategic Business Report   Global Industry Analysts, Inc., Aug 2010, Pages: 589 companies including many key and niche players such as Abbott Laboratories, Beckman Coulter Inc., bioMérieux, Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., Roche Diagnostics, and Siemens Cholesterol & Other Cardiovascular Testing - Global Strategic Business Report   Global Industry Analysts, Inc., Feb 2011, Pages: 293 Diagnostics 29 Table 3: Global Point of Care Diagnostics Market (2008): Percentage Breakdown of Value Sales by Segment - Hospital Labs, Commercial Labs, Self Medical Nanotechnology Markets   TriMark Publications, Sep 2008, Pages: 183 ? 5.12.17 How Are Nano-Optical Tagging Technologies Used in Animal Drug Safety Assessment Studies? 5.12.18 What Nanotechnology Platforms Are Being Used in Point of Care Diagnostic Testing? 6 Key Sector Insights and Forecasts for the Medical Equipment Industry in Japan   Global Markets Direct, Jan 2009, Pages: 82 .1 Overview 51 5.2 Key Points 52 5.3 Competitive Landscape 53 6 Diagnostic Imaging Equipment Market in Japan 55 6.1 Overview 55 6.2 Key Market Trends 57 6.3 Best Prospects 59 6.4 Competitive Landscape 59 7 European Hospital Financing Reform - Developments and Business Implications for the Medical Device Industry   HBS Consulting, June 2006, Pages: 113 health care technology. Company HTAs should include discussion of issues broader than pure cost-effectiveness studies e.g. ethics, psychosocial matters and organisational implications. Companies need The 2011-2016 World Outlook for Veterinary Pharmaceuticals, Medicinal Premixes, and Medicated Pet Care Products Excluding Diagnostic Preparations and Pet Flea-And-Tick Products   ICON Group International, Jan 2011, Pages: 200 , and medicated pet care products excluding diagnostic preparations and pet flea-and-tick products is not actual or historic sales. Nor is latent demand future sales. In fact, latent demand can be lower either Companion Biomarkers in Drug Development   TriMark Publications, April 2009, Pages: 320 for Companion Diagnostics 63 2.6.8 Key Stake Holders in Companion Diagnostics 63 2.9 Future Developments 65 3. Biomarker Development Tools 66 3.1 New Technologies in Functional Genomics 66 3.1.1 Genomics-Derived The 2011-2016 Outlook for Sleep Apnea Diagnostic and Therapeutic Devices in Africa   ICON Group International, Jan 2011, Pages: 60 and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand. THE METHODOLOGY In order The 2011-2016 Outlook for Sleep Apnea Diagnostic and Therapeutic Devices in Asia   ICON Group International, Jan 2011, Pages: 39 and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand. THE METHODOLOGY In order The 2011-2016 Outlook for Sleep Apnea Diagnostic and Therapeutic Devices in Europe   ICON Group International, Jan 2011, Pages: 55 and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand. THE METHODOLOGY In order The 2011-2016 Outlook for Sleep Apnea Diagnostic and Therapeutic Devices in Latin America   ICON Group International, Jan 2011, Pages: 36 . Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand. THE METHODOLOGY The 2011-2016 Outlook for Sleep Apnea Diagnostic and Therapeutic Devices in North America & the Caribbean   ICON Group International, Jan 2011, Pages: 37 at the aggregate level. Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand The 2011-2016 Outlook for Sleep Apnea Diagnostic and Therapeutic Devices in Oceana   ICON Group International, Jan 2011, Pages: 35 and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand. THE METHODOLOGY In order The 2011-2016 Outlook for Sleep Apnea Diagnostic and Therapeutic Devices in The Middle East   ICON Group International, Jan 2011, Pages: 37 . Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand. THE METHODOLOGY The 2011-2016 World Outlook for Sleep Apnea Diagnostic and Therapeutic Devices   ICON Group International, Jan 2011, Pages: 208 . Product and service offering details, and the actual identity of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand. THE METHODOLOGY The 2011-2016 Outlook for Sleep Apnea Diagnostic and Therapeutic Devices in Greater China   ICON Group International, Jan 2011, Pages: 143 for sleep apnea diagnostic and therapeutic devices at the aggregate level. Product and service offerings, and the actual identity of the players involved, while important for certain issues, are relatively The 2009-2014 World Outlook for Veterinary Pharmaceuticals, Medicinal Premixes, and Medicated Pet Care Products Excluding Diagnostic Preparations and Pet Flea-And-Tick Products   ICON Group International, Sep 2008, Pages: 200 , and medicated pet care products excluding diagnostic preparations and pet flea-and-tick products is not actual or historic sales. Nor is latent demand future sales. In fact, latent demand can be lower either The 2011-2016 World Outlook for Hospital Care   ICON Group International, Jan 2011, Pages: 187 of the players involved, while important for certain issues, are relatively unimportant for estimates of latent demand. THE METHODOLOGY In order to estimate the latent demand for hospital care on a worldwide Issuer Ranking: U.S. Health Care Companies, Strongest To Weakest Oct 07   Standard & Poors, Oct 2007, Pages: 187 Inc.,DJO Global Inc.,Triumph HealthCare Holdings Inc.,Center for Diagnostic Imaging Inc.,InterDent Inc.,PharmaNet Development Group Inc.,Emergency Medical Services Corp.,Diagnostic Imaging Group LLC,CRC Results:  First -   Prev -   1 -   2 -   3 -   4 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network